The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.
There are only 69 NCI-designated cancer centers in the United States, and just 45 of them are designated “comprehensive.” UC Davis was first designated in 2002, gaining comprehensive status in 2012.
The cancer center’s designation was based on an evaluation a 1,761-page grant proposal that detailed the accomplishments within each of the center’s research programs as well as a day-long visit to the center in March by a 22-member committee, made up of NCI officials and NCI cancer center researchers from around the country.
Cancer Center Director Ralph de Vere White, who led the cancer center’s grant proposal submission and site visit, said the NCI’s stamp of approval not only brings with it important grant funding to support programs and research, but confirmation that the center is truly a resource for all residents in inland Northern California.
“The NCI has certified that we have demonstrated our expertise in many disciplines that contribute to understanding, diagnosing, preventing and treating cancer,” he said. “But we cannot rest on our accomplishments. Our mission is clear, to continue working to reduce mortality from advanced disease and break barriers to beat cancer in our region and beyond.”